You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Aldel Financial II Inc.’s Nasdaq securities face delisting, with trading suspension set for November 6, 2026; its securities may then be quoted and traded over the counter. It issued an interest-free unsecured promissory note of up to $1,000,000.
Aldel Financial II Inc. shareholders approved extending its business-combination deadline monthly, up to fifteen times, from October 23, 2026 until January 23, 2028, with $50,000 deposited per extension, and elected to redeem 19,690,019 ordinary shares.
Aldel Financial II Inc. reported that all but one Class B ordinary share will convert to Class A ordinary shares on October 5, 2026, leaving 29,868,213 Class A Shares and one Class B Share outstanding.
ALDF proposes extending its business-combination deadline from October23,2026 to January23,2028 through fifteen(15) monthly extensions, each requiring $50,000, and reducing liquidation-expense withdrawals from $100,000 to $25,000.
Illustrative technical + ownership context — a signal mix, not investment advice.
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ALDFU
this stock
Aldel Financial II Inc.
|
$109.42M | +1.6% | — | — | — |
|
VYLR
Vylor Inc.
|
$46.80B | — | — | — | 2.2% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$650.38M | +3.1% | — | — | 0.0% |
|
CCXI
Churchill Capital Corp XI
|
$627.18M | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ALDFU | +0.7% | +0.7% | +6.3% | +0.0% | +1.6% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | +1.4% | +0.6% | -5.8% | +0.6% | -10.3% |
